2025-02-11
Objective: To observe the efficacy of intraperitoneal circulation hyperthermic perfusion chemotherapy in the treatment of malignant ascites.
2025-02-11
The National Cancer Center has just released: 2024 National Cancer Report
Recently, approved by the National Health Commission, the National Cancer Center released the 2022 burden of malignant tumors in China based on the latest data from tumor registration and follow-up monitoring on JNCC.
2025-02-11
In the past two years, the use of constant temperature circulating thermal perfusion for intraperitoneal and venous double-route hyperthermic chemotherapy has achieved satisfactory results in preventing and treating intraperitoneal metastatic cancer, which cannot be achieved by non-circulating thermal perfusion chemotherapy.
2025-02-11
Objective: To explore the nursing methods for treating malignant ascites with normothermic hyperthermic perfusion chemotherapy during extracorporeal circulation.
2025-02-11
Clinical observation of hot infusion chemotherapy for malignant pleural effusion
Objective: To observe the clinical effects and adverse reactions of extracorporeal high-frequency hyperthermia combined with intrathoracic thermal perfusion chemotherapy in the treatment of malignant pleural effusion.
2025-02-11
Objective: To evaluate the clinical efficacy, quality of life, and toxic side effects of oral S-1 combined with intraperitoneal hyperthermic chemotherapy in the treatment of advanced gastric cancer with ascites.
2025-02-11
Objective: To explore the efficacy of continuous circulating hyperthermic intrathoracic chemotherapy at a temperature of 42-43°C for malignant pleural effusion.
2025-02-11
Objective: To evaluate the clinical efficacy of early application of intraperitoneal perfusion machine for intraperitoneal circulation hyperthermic perfusion chemotherapy after gastric cancer surgery.
2025-02-11
Objective: To observe the clinical efficacy of loop thermal infusion chemotherapy in the treatment of malignant ascites.
2025-02-11
Objective: This study mainly analyzes and discusses the efficacy of circulating hyperthermic perfusion chemotherapy in patients with advanced gastric cancer complicated by ascites, in order to provide a reference for the clinical treatment of such patients.